News

In addition, the companies have formed a partnership that will leverage the strengths of both organizations to identify and develop new drugs. The five-year investment gives Takeda the

Earlier, Pfizer agreed to make an upfront payment of $225m to InnoPharma and up to $135m of contingent milestone payments. InnoPharma has developed capabilities in complex injectable delivery

Actavis’ ANDA product is a generic version of Purdue Pharma’s Butrans, which is indicated for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment

"We thank Servier for their contribution in forwarding abexinostat to its current stage of development, which includes having filed the patent applications that could extend patent protection to

In the U.S., the designation carries significant incentives for the development of drugs to treat rare and difficult diseases. The Company is preparing to commence a Phase 2

Originated from the labs of David Baltimore, Nobel Laureate and President Emeritus, and Robert Andrews, Millikan Professor of Biology at Caltech, the technology uses the patient’s own hematopoietic

MM-398 is an investigational drug candidate designed to increase drug deposition and prolong cytotoxic effects, with the goal of improving its anti-cancer properties. Currently, Merrimack is preparing a

Under the deal, Sothema will be responsible for marketing and selling Zestra and its high viscosity water-based lubricant Zestra Glide in Middle East (Excluding Lebanon and Israel), North

More than 10,000 mosquitoes infected with bacteria that suppress dengue fever have been released by scientists at the Rio de Janeiro-based Fiocruz research institute to let them multiply